Gastrointestinal stromal tumor

FDA

FDA expands approval of Bayer cancer drug

WASHINGTON (AP) — The Food and Drug Administration on Monday expanded approval of a Bayer cancer pill to treat tumors of the intestinal tract that don’t respond to other treatments.

02/25/2013